Pharma & Biotech

Investors in Ocugen, a biotechnology firm focused on genetic treatments for rare eye diseases, were met with unsettling news in...

The clinical-stage biopharmaceutical company Annexon, Inc. is currently riding a significant wave of positive analyst coverage. In a concentrated period,...

Shares of Galectin Therapeutics declined for a third consecutive trading day on Tuesday, closing at $5.46. The session's loss amounted...

Viking Therapeutics, a clinical-stage biopharmaceutical company, captured significant investor interest this week following its presentation at the Piper Sandler Healthcare...

After an extraordinary surge that saw its value multiply more than fourfold this year, Cogent Biosciences is experiencing a significant...

A significant deadline has arrived for one of Germany's most closely watched biotech narratives. The offer period for BioNTech's exchange...

The year 2025 is shaping up to be a formidable challenge for Novo Nordisk, with its share price having plummeted...

Investors in Redcare Pharmacy are witnessing a relentless sell-off, with the stock's value eroding rapidly. The critical question now is...

Bionxt Solutions has announced a major strategic expansion, positioning itself to access a multi-billion dollar segment within the oncology and...

Shares of Intellia Therapeutics are experiencing significant downward pressure, with the stock price declining 3.80% to $8.10 as investor sentiment...